Cavitation Technologies, Inc. and Desmet Belgium S.A Sign Agreement That Will Allow CTi to Monetize Parts of Its IP Portfolio While Retaining Worldwide Exclusive Licenses in Its Primary Business Lines
October 14, 2024 09:00 ET
|
Cavitation Technologies, Inc
CHATSWORTH, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB:CVAT), a leading ESG company designing and manufacturing innovative flow-through...
Valour, eine Tochtergesellschaft von DeFi Technologies, erweitert sein Angebot auf Spotlight Stock Market mit Valour Sui (SUI) ETP
October 11, 2024 08:28 ET
|
DeFi Technologies Inc.
Einführung des Valour Sui (SUI) ETP: Valour, eine Tochtergesellschaft von DeFi Technologies, hat mit dem Valour Sui (SUI) ETP ihr Angebot an innovativen digitalen Anlageprodukten auf dem schwedischen...
Valour, filiale de DeFi Technologies, élargit son offre avec l’ETP Valour Sui (SUI) sur le marché boursier Spotlight
October 11, 2024 08:28 ET
|
DeFi Technologies Inc.
Introduction de l’ETP Valour Sui (SUI) : Valour, filiale de DeFi Technologies, a lancé l’ETP Valour Sui (SUI) sur le marché boursier suédois Spotlight, élargissant ainsi son portefeuille de produits...
DeFi Technologies' Subsidiary Valour Expands Offerings with Valour Sui (SUI) ETP on Spotlight Stock Market
October 10, 2024 07:30 ET
|
DeFi Technologies Inc.
Valour has launched the Valour Sui (SUI) ETP on Sweden’s Spotlight Stock Market, broadening its portfolio of innovative digital asset products.
Starke Cresemba® (Isavuconazol)-Umsätze in Asien-Pazifik und China lösen vierte Meilensteinzahlung für diese Region in diesem Jahr an Basilea aus
October 10, 2024 01:15 ET
|
Basilea Pharmaceutica AG, Allschwil
Allschwil, 10. Oktober 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year
October 10, 2024 01:15 ET
|
Basilea Pharmaceutica AG, Allschwil
Allschwil, Switzerland, October 10, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
Brunswick Reports Additional Lithium Assays on Globex’s Lac Escale (Mirage) Royalty Area
October 08, 2024 13:43 ET
|
Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, Oct. 08, 2024 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
Draganfly Announces Board Update
October 08, 2024 07:30 ET
|
Draganfly Inc
Advisory Board Welcomes Former White House Chief of Staff Andy Card and Kim Moody as Audit Chair Saskatoon, SK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE:...
Prospera Energy Inc. Announces Cash Flow Optimization
October 03, 2024 02:00 ET
|
Prospera Energy Inc.
CALGARY, Alberta, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (PEI: TSX-V; OF6A: FRA) ("Prospera" or the "Corporation") Prospera Energy Inc. (PEI) is pleased to announce the prompt full...
Consolidated Lithium Reports Drilling on Globex Royalty Claims
October 02, 2024 10:03 ET
|
Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, Oct. 02, 2024 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...